Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib + Abemaciclib in Advanced Ovarian Cancer
NCT06594679Phase 2Recruiting
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Sep 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Sep 2024; status: recruiting.
02
Drugs
abemaciclib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT06594679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06594679.